Skip to main content

Advertisement

Log in

Risk of Sjögren’s syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case–control study

  • Short Communication - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Primary Sjögren’s syndrome (pSS) is a progressive systemic autoimmune disorder with a strong female predominance. Hormonal influences are thought to play a role in the development of pSS. However, no studies have specifically evaluated the association between irregular menstrual cycles and pSS. Therefore, using a health claims database, this study investigated the risk of pSS in women with irregular menstrual cycles. We conducted a case–control study using the Taiwan’s National Health Insurance Research Database. A total of 360 patients diagnosed with pSS (International Classification of Diseases, ninth revision, clinical modification, ICD-9-CM code 710.2) between 2001 and 2012 were identified. Controls were frequency-matched at a rate of 5:1 to the cases by five-year age interval and index year. Both cases and controls were retrospectively traced back until 2001 for the diagnosis of irregular menstrual cycles (ICD-9-CM code 626.4). The risk of pSS was assessed using multivariate logistic regression analyses. Irregular menstrual cycles were significantly associated with pSS [adjusted odds ratio, (AOR) = 1.38, p = 0.027], after adjusted for insured amount, urbanization level, and thyroid disorder. In addition, when the data were stratified by three age categories, only the patients in the age category of 45–55 years showed significant association between irregular menstrual cycles and pSS (AOR = 1.74, p = 0.005). In this nationwide, population-based case–control study, we found a significant increased risk of pSS in female patients with irregular menstrual cycles, particularly those in their mid-forties to mid-fifties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rosenfield RL (2013) Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab 98(9):3572–3583

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1(3):235–245

    Article  PubMed  CAS  Google Scholar 

  3. Franks S, Adams J, Mason H, Polson D (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 12(3):605–632

    PubMed  CAS  Google Scholar 

  4. Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE (2001) Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286(19):2421–2426

    Article  PubMed  CAS  Google Scholar 

  5. Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87(5):2013–2017

    Article  PubMed  CAS  Google Scholar 

  6. Wang ET, Cirillo PM, Vittinghoff E, Bibbins-Domingo K, Cohn BA, Cedars MI (2011) Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab 96(1):E114–E118

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Minami Y, Sasaki T, Komatsu S, Nishikori M, Fukao A, Yoshinaga K, Hisamichi S (1993) Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 169(3):245–252

    Article  PubMed  CAS  Google Scholar 

  8. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262

    Article  PubMed  Google Scholar 

  9. Reksten TR, Jonsson MV (2014) Sjögren’s syndrome: an update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am 26:1–12

    Article  PubMed  Google Scholar 

  10. Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjogren’s syndrome in Taiwan: a population-based study. J Rheumatol 38:706–708

    Article  PubMed  Google Scholar 

  11. Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM (1994) Obstetric and gynaecological profile in patients with primary Sjögren’s syndrome. Ann Rheum Dis 53:569–573

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Marchesoni D, Mozzanega B, De Sandre P, Romagnolo C, Gambari P, Maggino T (1995) Gynaecological aspects of primary Sjogren’s syndrome. Eur J Obstet Gynecol Reprod Biol 63(1):49–53

    Article  PubMed  CAS  Google Scholar 

  13. Mulherin DM, Sheeran TP, Kumararatne DS, Speculand B, Luesley D, Situnayake RD (1997) Sjögren’s syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 104(9):1019–1023

    Article  PubMed  CAS  Google Scholar 

  14. Haga HJ, Gjesdal CG, Irgens LM, Ostensen M (2005) Reproduction and gynaecological manifestations in women with primary Sjögren’s syndrome: a case-control study. Scand J Rheumatol 34(1):45–48

    Article  PubMed  CAS  Google Scholar 

  15. National Health Insurance Administration (2014) 2014–2015 National Health Insurance Annual Report. http://www.nhi.gov.tw/Resource/webdata/13767_1_NHI2014-2015%20Annual%20Report%20%28bilingual%29_141230.pdf

  16. National Health Insurance Research Database, Taiwan. http://nhird.nhri.org.tw/en/

  17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61(6):554–558

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Lu MC, Yin WY, Tsai TY, Koo M, Lai NS (2013) Increased risk of primary Sjögren’s syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS ONE 8(10):e77210

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage 4:1–22 (in Chinese)

    CAS  Google Scholar 

  20. Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175–180

    Article  PubMed  CAS  Google Scholar 

  21. Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26(3):436–441

    PubMed  CAS  Google Scholar 

  22. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262

    Article  PubMed  Google Scholar 

  23. Shen SY, Huang SY, Hsieh CH, Hsu MI, Cheng CY, Hsu CS (2014) Clinical and biochemical characteristics of women with menstrual disturbance. Taiwan J Obstet Gynecol 53(2):178–182

    Article  PubMed  Google Scholar 

  24. Oertelt-Prigione S (2012) The influence of sex and gender on the immune response. Autoimmun Rev 11(6–7):A479–A485

    Article  PubMed  CAS  Google Scholar 

  25. Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol 35(3):347–369

    Article  PubMed  CAS  Google Scholar 

  26. Porola P, Laine M, Virkki L, Poduval P, Konttinen YT (2007) The influence of sex steroids on Sjögren’s syndrome. Ann N Y Acad Sci 1108:426–432

    Article  PubMed  CAS  Google Scholar 

  27. Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y (2012) Sex steroids in Sjögren’s syndrome. J Autoimmun 39(1–2):49–56

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare, or the National Health Research Institutes.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Malcolm Koo or Ning-Sheng Lai.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Ming-Chi Lu and Min-Chih Hsieh contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, MC., Hsieh, MC., Koo, M. et al. Risk of Sjögren’s syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case–control study. Rheumatol Int 36, 155–160 (2016). https://doi.org/10.1007/s00296-015-3324-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3324-z

Keywords

Navigation